RTI Surgical closes $300m Paradigm Spine buy | 合法醫療器材資訊網

2019年3月11日—“TheacquisitionofParadigmalignswithRTI'sgrowthstrategyfocusedoninvestingindifferentiatedproductsandbuildingscalewithinourspine ...

RTI Surgical[1] (NSDQ:RTIX[2]) said last week that it closed the $300 million acquisition of Paradigm Spine[3] and its Coflex lumbar stenosis device.

The cash-and-stock deal, originally announced last November[4], called for RTI to pay $100 million in cash and more than 10.7 million shares of its own stock worth $50 million, with the $150 million balance pegged to unspecified milestones in cash and stock.

New York City-based Paradigm’s Coflex device won pre-market approval from the FDA[5] in 2012.

“The acquisition of Paradigm aligns with RTI’s growth strategy focused on investing in differentiated products and building scale within our spine business,” RTI president & CEO Camille Farhat said[6] in prepared remarks. “The addition of Coflex allows RTI to provide surgeons who treat patients with moderate to severe LSS ...